Even with a booster, protection against severe disease from Omicron may be around 80 to 85.9%, compared to around 97% for ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality ... during future outbreaks of ...

"Very high" levels of the virus were detected by the CDC in New Mexico, with "high" levels in Oregon, Arkansas, and Maine.

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...

A Delta plane had visible damage to its nose from a mechanical issue, but landed safely at its destination in Denver on ...

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution ...

This year’s COVID-19 booster was rolled out in doctors offices and pharmacies in September, and attempts to address the rise ...

Zhu, J. , Zheng, C. , Cai, X. , Qiu, X. , Zhang, C. , Huang, D. and Tao, Y. (2024) Feelings and Thoughts of Infected Nursing ...